BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30773735)

  • 1. Variation in cardiovascular magnetic resonance myocardial contouring: Insights from an international survey.
    Moody WE; Hudsmith LE; Holloway B; Treibel TA; Davies R; Kozor R; Hamilton-Craig C; Edwards NC; Bradlow WM; Moon JC; Steeds RP;
    J Magn Reson Imaging; 2019 Oct; 50(4):1336-1338. PubMed ID: 30773735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Myocardial Extracellular Volume Fraction.
    Fent GJ; Garg P; Foley JRJ; Swoboda PP; Dobson LE; Erhayiem B; Treibel TA; Moon JC; Greenwood JP; Plein S
    JACC Cardiovasc Imaging; 2017 Nov; 10(11):1402-1404. PubMed ID: 28216005
    [No Abstract]   [Full Text] [Related]  

  • 3. Automated Cardiac MR Scar Quantification in Hypertrophic Cardiomyopathy Using Deep Convolutional Neural Networks.
    Fahmy AS; Rausch J; Neisius U; Chan RH; Maron MS; Appelbaum E; Menze B; Nezafat R
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1917-1918. PubMed ID: 30121270
    [No Abstract]   [Full Text] [Related]  

  • 4. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
    Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
    J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.
    Nam BD; Kim SM; Jung HN; Kim Y; Choe YH
    Int J Cardiovasc Imaging; 2018 Nov; 34(11):1769-1777. PubMed ID: 29846837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial fibrosis: why image, how to image and clinical implications.
    Bing R; Dweck MR
    Heart; 2019 Dec; 105(23):1832-1840. PubMed ID: 31649047
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial fibrosis evaluated by Look-Locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: association with ventricular tachyarrhythmia and risk factors.
    Amano Y; Takeda M; Tachi M; Kitamura M; Kumita S
    J Magn Reson Imaging; 2014 Aug; 40(2):407-12. PubMed ID: 24924216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of regional myocardial structure and function in hypertrophic cardiomyopathy and amyloidois: a combined two-dimensional speckle tracking and cardiovascular magnetic resonance analysis.
    Pagourelias ED; Mirea O; Vovas G; Duchenne J; Michalski B; Van Cleemput J; Bogaert J; Vassilikos VP; Voigt JU
    Eur Heart J Cardiovasc Imaging; 2019 Apr; 20(4):426-437. PubMed ID: 30085025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histogram Analysis of Native T
    Wu CW; Wu R; Shi RY; An DA; Chen BH; Jiang M; Bacyinski A; Rahim A; Deen JM; Hu J; Han TT; Xu JR; Wu LM
    J Magn Reson Imaging; 2019 Mar; 49(3):668-677. PubMed ID: 30142234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients.
    Kim EK; Lee SC; Hwang JW; Chang SA; Park SJ; On YK; Park KM; Choe YH; Kim SM; Park SW; Oh JK
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):678-86. PubMed ID: 26245912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial perfusion assessment by use of system identification method in a one-compartment model.
    Kocher M; Daire JL; Thevenaz P; Schindler T; Keller PF; Didier D; Vallee JP
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():4492-5. PubMed ID: 18003003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
    Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
    J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging for hypertrophic cardiomyopathy update.
    Chan AK; Somarouthu B; Ghoshhajra B
    Top Magn Reson Imaging; 2014 Feb; 23(1):33-41. PubMed ID: 24509622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy masquerading as sarcoidosis: cases illustrating cardiac imaging overlap relative to pathology.
    Sellers SL; Ellis J; Lai A; Salcudean H; Reid AB; Blanke P; McManus BM; Leipsic JA; Seidman MA
    Cardiovasc Pathol; 2020; 49():107234. PubMed ID: 32585602
    [No Abstract]   [Full Text] [Related]  

  • 17. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring myocardial scar by CMR.
    Kwong RY; Farzaneh-Far A
    JACC Cardiovasc Imaging; 2011 Feb; 4(2):157-60. PubMed ID: 21329900
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial T2 Mapping in Patients With Hypertrophic Cardiomyopathy.
    Amano Y; Yanagisawa F; Tachi M; Hashimoto H; Imai S; Kumita S
    J Comput Assist Tomogr; 2017; 41(3):344-348. PubMed ID: 27763940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracardiac 4D Flow MRI in Congenital Heart Disease: Recommendations on Behalf of the ISMRM Flow & Motion Study Group.
    Zhong L; Schrauben EM; Garcia J; Uribe S; Grieve SM; Elbaz MSM; Barker AJ; Geiger J; Nordmeyer S; Marsden A; Carlsson M; Tan RS; Garg P; Westenberg JJM; Markl M; Ebbers T
    J Magn Reson Imaging; 2019 Sep; 50(3):677-681. PubMed ID: 31317587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.